BackJasper Therapeutics- Warrants (24/09/2026) Overview

Jasper Therapeutics- Warrants (24/09/2026) Accounts Payable

Latest accounts payable for JSPRW: $2.4M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$2.44M
↓ 18.56% YoYΔ $-556000.00 vs prior year quarter

Peer average

Loading

Jasper Therapeutics- Warrants (24/09/2026) Accounts Payable History

Loading

Jasper Therapeutics- Warrants (24/09/2026) vs. peers: Accounts Payable Comparison

Loading

Jasper Therapeutics- Warrants (24/09/2026) Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Jasper Therapeutics- Warrants (24/09/2026) (JSPRW) FAQ

As of the most recent data (March 2026), JSPRW shows a accounts payable of $2.4M. That compares with $3M in the prior-year period — down 18.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, JSPRW's accounts payable is now $2.4M (was $3M) — a 18.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Jasper Therapeutics- Warrants (24/09/2026) is outperforming or lagging.

Tracking JSPRW's accounts payable over time shows whether Jasper Therapeutics- Warrants (24/09/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.4M That compares with $3M in the prior-year period — down 18.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Jasper Therapeutics- Warrants (24/09/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.4M) with ownership activity and broader fundamentals.